Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NUS · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Nu Skin Enterprises (NUS) · oqro.io/stocks/NUS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.80+0.03 (+0.80%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
5%+ stake · Stake as of Sep 30, 2026 · Filed Nov 16, 2026
American Century Investment Management, Inc. now owns 5.5% of NUS as a passive investorSourceInsider trade · Traded Jun 2, 2026 · Filed Jun 3, 2026
Director sold ~$40K of NUS shares in the open marketSourceInsider trade · Traded Jun 1, 2026 · Filed Jun 3, 2026
Director sold ~$41K of NUS shares in the open marketSourceInsider trade · Traded May 11, 2026 · Filed May 12, 2026
Director sold ~$18K of NUS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 10, 2026
Hillsdale Investment Management Inc. disclosed a reduced position in NUS for Q4 2025SourceInsider trade · Traded Nov 11, 2025 · Filed Nov 12, 2025
Officer purchased ~$53K of NUS shares in the open marketSourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 10, 2025
Hillsdale Investment Management Inc. disclosed an increased position in NUS for Q3 2025SourceInsider trade · Traded Sep 3, 2025 · Filed Sep 4, 2025
Officer sold ~$239K of NUS shares in the open marketSourceInsider trade · Traded Sep 4, 2025 · Filed Sep 4, 2025
Director sold ~$79K of NUS shares in the open marketSourceInsider trade · Traded Aug 29, 2025 · Filed Aug 29, 2025
Director sold ~$283K of NUS shares in the open marketSourceInsider trade · Traded Aug 29, 2025 · Filed Aug 29, 2025
Director sold ~$110K of NUS shares in the open marketSourceInsider trade · Traded Jun 2, 2025 · Filed Jun 3, 2025
Director sold ~$38K of NUS shares in the open marketSourceInsider trade · Traded Jun 2, 2025 · Filed Jun 3, 2025
Director sold ~$38K of NUS shares in the open marketSourceInsider trade · Traded May 28, 2025 · Filed May 28, 2025
Officer purchased ~$49K of NUS shares in the open marketSourceInsider trade · Traded Feb 21, 2025 · Filed Feb 24, 2025
Director sold ~$13K of NUS shares in the open marketSourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Bridgewater Associates no longer reported NUS for Q4 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
Bridgewater Associates disclosed a reduced position in NUS for Q3 2024Source